Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
Objective: Polycystic ovary syndrome (PCOS) is associated with insulin resistance and obesity. Prospective population-based data regarding development and possible predictors of type 2 diabetes (T2D) in PCOS are limited. Design: National Patient Register-based study. Methods: Patients with PCOS [PCOS Denmark and embedded cohort, PCOS Odense University Hospital (OUH)] and a control population with no previous diagnosis of T2D. PCOS OUH (N = 1,162) included premenopausal women with PCOS and standardized clinical and biochemical examination. PCOS Denmark (N = 18,477) included women with PCOS in the Danish National Patient Register. Three age-matched controls were included per patient (N = 54,680). Main outcome: T2D events according to diagnosis codes and filled medicine prescriptions. Results: The median (quartiles) follow-up was 11.1 (6.9 to 16.0) years. The hazard ratio (HR) with 95% confidence interval (CI) for development of T2D in PCOS Denmark was HR = 4.0 (95% CI, 3.7 to 4.3; P < 0.001), and the total event rate of T2D was 8.0 per 1000 person years in PCOS Denmark vs 2.0 per 1000 person years in controls (P < 0.001). The median age at diagnosis of T2D was 31 (26 to 37) years in PCOS Denmark vs 35 (27 to 44) years in controls (P < 0.001). In multiple regression analyses, body mass index, glycated hemoglobin, fasting blood glucose, 2-hour blood glucose, homeostasis model assessment of insulin resistance, and triglycerides were positively associated with development of T2D, whereas higher number of births was negatively associated with development of T2D. Conclusion: The event rate of T2D was higher in PCOS compared with controls, and T2D was diagnosed at a younger age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PCOS is associated with increased co-morbidities including obesity, infertility, pregnancy complications, depression and anxiety, metabolic syndrome, diabetes, reproductive cancers and cardiovascular disease [3, 7, 8, 10–13].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [10]
In the citing paper
“PCOS is associated with a higher incidence of fertility assistance and complications of pregnancy, including gestational hypertension and diabetes.12,17,18,21, 22, 23, 24”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [17]
In the citing paper
“In addition, it is recognized that IR plays a major role in the pathophysiology of all of the metabolic diseases, cardiovascular disease, some neurodegenerative diseases, and selected cancers [22,157].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [157]
In the citing paper
“Women with PCOS experience increased cardiometabolic risk—including the metabolic syndrome, hypertension, insulin resistance, obesity and dyslipidemia—predisposing them to increased risk for diabetes and cardiovascular disease (CVD).2,10,17, 18, 19, 20”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [17]
In the citing paper
“The diagnosis of PCOS included the ICD-9 and ICD-10 codes, and these have been validated and used in previous epidemiologic studies.6,10,17,27,32,55, 56, 57”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [17]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · cited 4×
“001 1 3966 (21) 208 (19) 3758 (22) 5324 (10) 62 (6) 5262 (10) 2 4106 (22) 90 (8) 4016 (23) 6494 (12) 24 (2) 6470 (12) $3 31 (3) 31 (3) 1382 (8) 2392 (4) 13 (1) 2379 (4)”
BackgroundInfluentialWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939
Research works printed but not linked: 1
- 2012, Polycystic ovary syndrome: an update, Aust Fam Physician, 41, 752
Cited by
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.12531 · Cited by 480
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
Wekker, V, van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., Laven, J. S. E., Roeters van Lennep, J. E., Roseboom, T. J., & Hoek, A. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa029 · Cited by 425
“Four studies scored low risk of bias on all eight criteria (nine stars), indicating these studies were of the highest quality (Table III) (Morgan et al., 2012; Kazemi Jaliseh et al., 2017; Rubin et al., 2017; Glintborg et al., 2018).”
BackgroundInfluentialZhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Dapas, M., Lin, F. T. J., Nadkarni, G. N., Sisk, R., Legro, R. S., Urbanek, M., Hayes, M. G., & Dunaif, A. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003132 · Cited by 297
“It is the leading cause of anovulatory infertility and a major risk factor for T2D in young women [14].”
BackgroundRajendran, A., Minhas, A. S., Kazzi, B., Varma, B., Choi, E., Thakkar, A., & Michos, E. D. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117269 · Cited by 243
Epigenetic inheritance of polycystic ovary syndrome — challenges and opportunities for treatment
Stener-Victorin, E., & Deng, Q. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00517-x · Cited by 212
Luo, H., Zhang, Q., Yu, K., Meng, X., Kan, H., & Chen, R. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104282 · Cited by 209
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0680-5 · Cited by 200
“Furthermore, testosterone levels did not predict the risk of T2D in PCOS OUH [10].”
BackgroundMethodResultInfluentialSelf-citationDiagnosis of Polycystic Ovary Syndrome
Chang, S., & Dunaif, A. E. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.002 · Cited by 190
Polycystic ovary syndrome as a metabolic disease
Helvaci, N., & Yildiz, B. O. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 188
The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
Kakoly, N. S., Earnest, A., Teede, H. J., Moran, L. J., & Joham, A. E. (2019) · Diabetes Care · doi:10.2337/dc18-1738 · Cited by 174
Characteristics of polycystic ovary syndrome throughout life
Louwers, Y. V., & Laven, J. S. E. (2020) · Therapeutic Advances in Reproductive Health · doi:10.1177/2633494120911038 · Cited by 174
Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
Sharpe, A., Morley, L. C., Tang, T., Norman, R. J., & Balen, A. H. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013505 · Cited by 132
Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review
Livadas, S., Anagnostis, P. G., Bosdou, J. Κ., Bantouna, D., & Paparodis, R. D. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i1.5 · Cited by 131
Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
Parker, J., O’Brien, C., Hawrelak, J., & Gersh, F. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031336 · Cited by 114
“In addition, it is recognized that IR plays a major role in the pathophysiology of all of the metabolic diseases, cardiovascular disease, some neurodegenerative diseases, and selected cancers (22,156).”
BackgroundPolycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
parker, J., O'Brien, C., Hawrelak, J., & Gersh, F. (2021) · doi:10.20944/preprints202112.0088.v1 · Cited by 113
Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study
Subramanian, A., Anand, A., Adderley, N. J., Okoth, K., Toulis, K. A., Gokhale, K. M., Sainsbury, C. A. R., O’Reilly, M., Arlt, W., & Nirantharakumar, K. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1163 · Cited by 104
The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits
Lüll, K., Arffman, R. K., Sola‐Leyva, A., Molina, N. M., Aasmets, O., Herzig, K., Plaza‐Díaz, J., Franks, S., Morin-Papunen, L. C., Tapanainen, J. S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa848 · Cited by 95
Insulin Resistance is Associated with Depression Risk in Polycystic Ovary Syndrome
Greenwood, E. A., Pasch, L. A., Cedars, M. I., Legro, R. S., Eisenberg, E., & Huddleston, H. G. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.03.009 · Cited by 88
“Women with PCOS are at increased risk of diabetes, obesity and metabolic syndrome (4, 5).”
BackgroundKonieczna, A., Rachoń, D., Owczarek, K., Kubica, P., Kowalewska, A., Kudłak, B., Wasik, A., & Namieśnik, J. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.09.006 · Cited by 88
Emerging role of testosterone in pancreatic β cell function and insulin secretion
Xu, W., Morford, J., & Mauvais-Jarvis, F. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0573 · Cited by 81
Androgen Excess in Pancreatic β Cells and Neurons Predisposes Female Mice to Type 2 Diabetes
Navarro, G., Allard, C., Morford, J. J., Xu, W., Liu, S., Molinas, A. J. R., Butcher, S. M., Fine, N. H. F., Blandino-Rosano, M., Sure, V. N., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98607 · Cited by 80
Ng, N. Y. H., Jiang, G., Cheung, L. P., Zhang, Y., Tam, C. H. T., Luk, A. O. Y., Quan, J., Lau, E. S. H., Yau, T., Chan, M. H. M., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002953 · Cited by 77
An Update on Contraception in Polycystic Ovary Syndrome
Oguz, S. H., & Yildiz, B. O. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.958 · Cited by 76
“Based on limited data, the risk of developing diabetes in women with PCOS during later years of life appears to be related to higher BMI, abdominal obesity, and insulin resistance, but not hyperandrogenism [67,68].”
BackgroundReproductive risk factors across the female lifecourse and later metabolic health
Nichols, A. R., Chavarro, J. E., & Oken, E. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.002 · Cited by 76
Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model
Aflatounian, A., Edwards, M. C., Paris, V. R., Bertoldo, M. J., Desai, R., Gilchrist, R. B., Ledger, W. J., Handelsman, D. J., & Walters, K. A. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0530 · Cited by 74
O’Reilly, M. W., Glisic, M., Kumarendran, B., Subramanian, A., Manolopoulos, K. N., Tahrani, A. A., Keerthy, D., Muka, T., Toulis, K. A., Hanif, W., et al. (2019) · Clinical Endocrinology · doi:10.1111/cen.13862 · Cited by 72
Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
Kempegowda, P., Melson, E., Manolopoulos, K. N., Arlt, W., & O’Reilly, M. W. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820934319 · Cited by 70
Association among depression, symptom experience, and quality of life in polycystic ovary syndrome
Greenwood, E. A., Pasch, L. A., Cedars, M. I., Legro, R. S., & Huddleston, H. G. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.06.017 · Cited by 68
Mitochondrial Dysfunction in Polycystic Ovary Syndrome
Zeng, X., Huang, Q., Long, S.-L., Zhong, Q., & Mo, Z. (2020) · DNA and Cell Biology · doi:10.1089/dna.2019.5172 · Cited by 67
Polycystic ovary syndrome: A metabolic disorder with therapeutic opportunities
Zhang, Y., Chen, Z., & Zhao, H. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.08.002 · Cited by 66
Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome
Persson, S., Elenis, E., Türkmen, Ş., Kramer, M. S., Yong, E., & Poromaa, I. S. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.04.018 · Cited by 66
The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
Meun, C., Gunning, M. N., Louwers, Y. V., Peters, H., Roos‐Hesselink, J., Roeters van Lennep, J., Rueda Ochoa, O., Appelman, Y., Lambalk, N., Boersma, E., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14117 · Cited by 65
Greenwood, E. A., Yaffe, K., Wellons, M. F., Cedars, M. I., & Huddleston, H. G. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00234 · Cited by 64
Prevalence and Etiology of Eating Disorders in Polycystic Ovary Syndrome: A Scoping Review
Lalonde-Bester, S., Malik, M., Masoumi, R., Ng, K., Sidhu, S., Ghosh, M., & Vine, D. F. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100193 · Cited by 63
Sydora, B. C., Wilke, M. S., McPherson, M., Chambers, S., Ghosh, M., & Vine, D. F. (2023) · BMC Women's Health · doi:10.1186/s12905-023-02732-2 · Cited by 60
“PCOS is associated with increased co-morbidities including obesity, infertility, pregnancy complications, depression and anxiety, metabolic syndrome, diabetes, reproductive cancers and cardiovascular disease [3, 7, 8, 10–13].”
BackgroundInfluentialAge at menopause and mortality in Taiwan: A cohort analysis
Shen, T.-Y., Strong, C., & Yu, T. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.04.008 · Cited by 59
Evans, M., Morgan, A. R., Patel, D., Dhatariya, K., Greenwood, S. A., Newland‐Jones, P., Hicks, D., Yousef, Z. R., Moore, J., Kelly, B., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00963-2 · Cited by 58
Vine, D., Ghosh, M., Wang, T., & Bakal, J. (2024) · CJC Open · doi:10.1016/j.cjco.2023.12.010 · Cited by 53
“6,17,27,31,109 In our cohort, the median age of diagnosis of type 2 diabetes was 32 years, in both those with PCOS and non-PCOS controls.”
BackgroundResultInfluentialAnagnostis, P. G., Paparodis, R. D., Bosdou, J. Κ., Bothou, C., Μacut, D., Goulis, D. G., & Livadas, S. (2021) · Endocrine · doi:10.1007/s12020-021-02801-2 · Cited by 52
Spinedi, E., & Cardinali, D. P. (2018) · International Journal of Endocrinology · doi:10.1155/2018/1349868 · Cited by 52
Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease
Dubey, P., Reddy, S., Sharma, K., Johnson, S., Hardy, G., & Dwivedi, A. K. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02050-5 · Cited by 52
Rani, R., Hajam, Y. A., Kumar, R., Bhat, R. A., Rai, S., & Rather, M. A. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100161 · Cited by 50
Manti, M., Fornes, R., Pironti, G., Haworth, S. M., Zhuge, Z., Benrick, A., Carlström, M., Andersson, D. C., & Stener‐Victorin, E. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz180 · Cited by 49
Mitochondria in Sex Hormone-Induced Disorder of Energy Metabolism in Males and Females
Yin, L., Luo, M., Wang, R., Ye, J., & Wang, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.749451 · Cited by 48
Cardiometabolic Risk in Polycystic Ovary Syndrome
Cooney, L. G., & Dokras, A. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.11.001 · Cited by 44
Growth Hormone/Insulin Growth Factor Axis in Sex Steroid Associated Disorders and Related Cancers
Bleach, R., Sherlock, M., O’Reilly, M., & McIlroy, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.630503 · Cited by 44
Quercetin and polycystic ovary syndrome
Ma, C., Xiang, Q., Song, G., & Wang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1006678 · Cited by 43
Choi, S. K. Y., Venetis, C., Ledger, W., Havard, A., Harris, K., Norman, R. J., Jorm, L. R., & Chambers, G. M. (2022) · Human Reproduction · doi:10.1093/humrep/deac032 · Cited by 42
Hypertension in Polycystic Ovary Syndrome: Novel Insights
Macut, D., Mladenović, V., Bjekić-Macut, J., Livadas, S., Stanojlović, O., Hrnčić, D., Rašić-Marković, A., Milutinović, D. V., & Andrić, Z. (2020) · Current Hypertension Reviews · doi:10.2174/1573402115666190531071422 · Cited by 42
Palm, C. V. B., Glintborg, D., Kyhl, H. B., McIntyre, H. D., Jensen, R. C., Jensen, T. K., Jensen, D. M., & Andersen, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.030 · Cited by 41
Self-citationIncreased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2019) · Endocrine Connections · doi:10.1530/ec-19-0377 · Cited by 40
Self-citationPolycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies
Jacewicz‐Święcka, M., & Kowalska, I. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3054 · Cited by 38
Socioeconomic status in Danish women with polycystic ovary syndrome: A register‐based cohort study
Rubin, K. H., Andersen, M., Abrahamsen, B., & Glintborg, D. (2018) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13514 · Cited by 38
Self-citationDiagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?
Andersen, M., & Glintborg, D. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0237 · Cited by 36
Self-citationMolecular Insulin Actions Are Sexually Dimorphic in Lipid Metabolism
Ortiz-Huidobro, R. I., Velasco, M., Larqué, C., Escalona, R., & Hiriart, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.690484 · Cited by 36
Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome
Hanna, F., Wu, P., Heald, A. H., & Fryer, A. A. (2023) · BMJ · doi:10.1136/bmj-2022-071675 · Cited by 35
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Genetics of polycystic ovary syndrome (PCOS)
Louwers, Y. V., Visser, J. A., Dunaif, A. E., & Laven, J. S. E. (2025) · Reproduction · doi:10.1530/rep-25-0126 · Cited by 35
Melson, E., Davitadze, M., Malhotra, K., PCOS SEva working group, Mousa, A., Teede, H. J., Boivin, J., Thondan, M., Tay, C. T., & Kempegowda, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217468 · Cited by 34
Birthweight, Childhood Body Mass Index, Height and Growth, and Risk of Polycystic Ovary Syndrome
Aarestrup, J., Pedersen, D. C., Thomas, P. E., Glintborg, D., Holm, J., Bjerregaard, L. G., & Baker, J. L. (2021) · Obesity Facts · doi:10.1159/000515294 · Cited by 34
Self-citationMetabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review
Marchesan, L. B., Ramos, R. B., & Spritzer, P. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.759835 · Cited by 33
İlhan, G. A., Yıldızhan, B., & Pekin, T. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1519794 · Cited by 33
The impact of ageing and menopause in women with polycystic ovary syndrome
Helvaci, N., & Yildiz, B. O. (2022) · Clinical Endocrinology · doi:10.1111/cen.14558 · Cited by 32
Soares, J. M., Hayashida, S. A. Y., Marcondes, J. A. M., Maciel, G. A. R., Barcellos, C. R. G., Maffazioli, G. D. N., Monteiro, K. K. A. C., Turri, J. A. O., Azziz, R., & Baracat, E. C. (2023) · Biomedicines · doi:10.3390/biomedicines11123262 · Cited by 32
Liao, W., Huang, J., Lee, M.-T., Yang, Y., & Wu, C.-C. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.240 · Cited by 31
Pathogenesis of Reproductive and Metabolic PCOS Traits in a Mouse Model
Paris, V. R., Edwards, M. C., Aflatounian, A., Bertoldo, M. J., Ledger, W. J., Handelsman, D. J., Gilchrist, R. B., & Walters, K. A. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab060 · Cited by 30
Mokou, M., Yang, S., Zhan, B., Geng, S., Li, K., Yang, M., Yang, G., Deng, W., Liu, H., Liu, D., et al. (2020) · Mediators of Inflammation · doi:10.1155/2020/2483435 · Cited by 30
Circulating miRNAs in Women with Polycystic Ovary Syndrome: A Longitudinal Cohort Study
Udesen, P. B., Sørensen, A. E., Svendsen, R. P., Frisk, N. L. S., Hess, A. L., Aziz, M., Wissing, M. L., Englund, A. L. M., & Dalgaard, L. T. (2023) · Cells · doi:10.3390/cells12070983 · Cited by 29
Efficacy and safety of acupuncture for polycystic ovary syndrome: An overview of systematic reviews
Yang, H., Xiao, Z.-Y., Yin, Z., Zheng, Y., Liu, J., Xiao, Y.-Q., Zhou, Y., Li, J., Yang, J., & Liang, F. (2022) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2022.12.002 · Cited by 29
Sucquart, I. E., Nagarkar, R., Edwards, M. C., Paris, V. R., Aflatounian, A., Bertoldo, M. J., Campbell, R. E., Gilchrist, R. B., Begg, D. P., Handelsman, D. J., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqab020 · Cited by 28
Carbone, L., Davis, B. A., Fei, S. S., White, A. E., Nevonen, K. A., Takahashi, D. L., Vinson, A., True, C. A., Roberts, C. T., & Varlamov, O. (2019) · Scientific Reports · doi:10.1038/s41598-019-55291-8 · Cited by 28
Polycystic ovary syndrome: associations with cardiovascular disease
Benham, J. L., Goldberg, A., Teede, H. J., & Tay, C. T. (2023) · Climacteric · doi:10.1080/13697137.2023.2282689 · Cited by 27
Metabolic profile of women with PCOS in Brazil: a systematic review and meta-analysis
Spritzer, P. M., Ramos, R. B., Marchesan, L. B., de Oliveira, M., & Carmina, E. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00636-5 · Cited by 27
Barbu, E. M., Popescu, M. R., Popescu, A.-C., & Balanescu, S. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136864 · Cited by 27
Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci
Stamou, M. I., Smith, K. T., Kim, H., Balasubramanian, R., Gray, K. J., & Udler, M. S. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad664 · Cited by 28
Rasmussen, J., Selmer, C., Frøssing, S., Schou, M., Faber, J. O., Torp-Pedersen, C. T., Gislason, G., Køber, L., HOUGAARD, D. M., Cohen, A. S., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa050 · Cited by 26
Glintborg, D., Ollila, M., Møller, J. K., Pesonen, P., Persson, S., Elenis, E., Rubin, K. H., Gissler, M., Andersen, M., Poromaa, I. S., et al. (2024) · Human Reproduction · doi:10.1093/humrep/deae124 · Cited by 26
Self-citationKumarendran, B., O’Reilly, M., Subramanian, A., Šumilo, D., Toulis, K. A., Gokhale, K. M., Wijeratne, C. N., Coomarasamy, A., Tahrani, A. A., Azoulay, L., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0437 · Cited by 26
Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome
Livadas, S., Paparodis, R. D., Anagnostis, P. G., Gambineri, A., Bjekić-Macut, J., Petrović, T., Yıldız, B. O., Micić, D., Mastorakos, G. P., & Μacut, D. (2023) · Diagnostics · doi:10.3390/diagnostics13122067 · Cited by 24
Maternal prolactin is associated with glucose status and PCOS in pregnancy: Odense Child Cohort
Overgaard, M., Glintborg, D., Christesen, H. T., Jensen, T. K., & Andersen, M. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0144 · Cited by 24
Self-citationNovel Antidiabetic Medications in Polycystic Ovary Syndrome
Somagutta, M. K. R., Jain, M. S., Uday, U., Pendyala, S. K., Mahadevaiah, A., Mahmutaj, G., Jarapala, N., Gad, M. A., Srinivas, P. M., Sasidharan, N., et al. (2022) · Discoveries · doi:10.15190/d.2022.4 · Cited by 23
Aflatounian, A., Paris, V. R., Richani, D., Edwards, M. C., Cochran, B. J., Ledger, W. L., Gilchrist, R. B., Bertoldo, M. J., Wu, L. E., & Walters, K. A. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101583 · Cited by 23
Cussen, L., McDonnell, T., Miller, C., McIlroy, M., & O’Reilly, M. (2025) · Reproduction · doi:10.1530/rep-25-0102 · Cited by 23
Leone, M., Kuja‐Halkola, R., Levál, A., Butwicka, A., Skov, J., Zhang, R., Liu, S., Larsson, H., & Bergen, S. E. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21090954 · Cited by 21
Changes in Metabolic Profile in the Women with a History of PCOS—A Long-Term Follow-Up Study
Jacewicz‐Święcka, M., & Kowalska, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103367 · Cited by 21
Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome
Glintborg, D., Kolster, N. D., Ravn, P., & Andersen, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061455 · Cited by 21
Self-citationBishop, C. V., Takahashi, D. L., Mishler, E., Slayden, O. D., Roberts, C. T., Hennebold, J. D., & True, C. A. (2020) · Human Reproduction · doi:10.1093/humrep/deaa321 · Cited by 21
Jin, C., Qin, L., Liu, Z., Li, X., Gao, X., Cao, Y., Zhao, S., Wang, J., Han, T., Yan, L., et al. (2023) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.02.002 · Cited by 21
Medical Treatment and Comorbidity in Polycystic Ovary Syndrome: An Updated Review
Glintborg, D., & Andersen, M. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.02.014 · Cited by 20
Self-citationCardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome
Armeni, E., & Lambrinoudaki, I. V. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180828154006 · Cited by 20
Mínguez‐Alarcón, L., Frueh, L., Williams, P. L., James-Todd, T. M., Souter, I. C., Ford, J. B., Rexrode, K. M., Calafat, A. M., Hauser, R. B., & Chavarro, J. E. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155191 · Cited by 20
Differential Lipidomic Characteristics of Children Born to Women with Polycystic Ovary Syndrome
Zhang, Z., Liu, Y., Lv, J., Zhang, D., Hu, K., Li, J., Ma, J., Cui, L., & Zhao, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.698734 · Cited by 20
Skeletal Muscle Immunometabolism in Women With Polycystic Ovary Syndrome: A Meta-Analysis
Manti, M., Stener‐Victorin, E., & Benrick, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.573505 · Cited by 19
Ng, N. Y. H., Wu, H., Lau, E. S. H., Zhang, X., Yang, A., Tsang, A. Y. T., Yau, T., Kong, A. P. S., Ng, K., Chung, J. P. W., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110640 · Cited by 19
Key signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Christensen, L. L., Glintborg, D., Kristensen, T. T., Diederichsen, A. C. P., T'Sjoen, G. G., Frystyk, J., & Andersen, M. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-045714 · Cited by 19
Self-citationRavn, P., Gram, F., Andersen, M. S., & Glintborg, D. (2022) · Metabolites · doi:10.3390/metabo12121183 · Cited by 18
Self-citationAssociation between FGF19, FGF21 and lipocalin-2, and diabetes progression in PCOS
Cheng, F., Ng, N. Y. H., Tam, C. H. T., Zhang, Y., Lim, C. K. P., Jiang, G., Ng, A. C. W., Yau, T., Cheung, L. P., Xu, A., et al. (2021) · Endocrine Connections · doi:10.1530/ec-21-0082 · Cited by 18
Metadata
- Authors
- Rubin, K. H., Glintborg, D., Nybo, M., Abrahamsen, B., & Andersen, M.
- Affiliations
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Corresponding author
- Glintborg, Dorte
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-08-29
- Volume
- 102
- Issue
- 10
- Pages
- 3848-3857
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2751209738
- Cited by
- 195
- References
- 44
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 18 · 2023: 28 · 2022: 26 · 2021: 30 · 2020: 31 · 2019: 18 · 2018: 15 · 2017: 1
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, type 2 diabetes, diabetes risk factors, insulin resistance, body mass index, HbA1c, fasting blood glucose, HOMA-IR, triglycerides, parity, age at diabetes diagnosis, premenopausal women
- MeSH terms
- Adolescent, Adult, Child, Denmark, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Middle Aged, Polycystic Ovary Syndrome, Registries, Risk Factors, Case-Control Studies, Disease Progression, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.